Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 42708-179

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 42708-179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

42708-179-05 (42708 179 05 Rev 1)

42708-179-05 (42708 179 05   Rev 1)
Ondansetron Tablets USP, 8 mg, film-coated tablets in a package containing 5 tablets. The label indicates sample status, storage at controlled room temperature, and directions for use with blanks to fill in dosage details. Distributed by QPharma, Inc., Cedar Knolls, NJ. Includes NDC number 42708-179-05 and Rx Only designation.*
FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical Structure (Ondansetron Str)
Chemical structure of Ondansetron Hydrochloride, depicting its molecular arrangement with ring structures and attached functional groups as commonly represented in pharmaceutical chemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.